Remdesivir, tocilizumab being considered for 'restricted use' on severely-ill COVID-19 patients - The Hitavada 13-Jun-2020

Remdesivir, tocilizumab being considered for 'restricted use' on severely-ill COVID-19 patients - The Hitavada

ANTI-viral drug remdesivir and tocilizumab, an immunomodulator, are being considered for “restricted use” on severely ill COVID-19 patients on “emergency and compassionate grounds”, according to revised clinical management guidelines to be released soon. The …